Nancy Nagle MD in Oklahoma City, Oklahoma

Home Oklahoma Oklahoma City

Nancy Nagle MD has Pulmonary Disease as her primary medical specialty. Their primary office is: 3366 Nw Expressway in Oklahoma City, Oklahoma. There are 2 additional office locations for Nancy Nagle MD that can be viewed towards the end of their profile. They attended University Of Oklahoma College Of Medicine and graduated in 1995 (around 29 years of experience). They are not listed as doing telehealth appointments, but this may have changed. It can't hurt to call and check. If anything it may encourage them to make them available if they are not currently.

Nancy N Nagle MD Office Phone and Directions

Nancy Nagle MD
3366 Nw Expressway
Oklahoma City, Oklahoma 73112
405-947-3345

Patient Ratings
Please rate your experience with Nancy Nagle MD below to help others make a more informed decision. Thanks!

Current Rating: Loading...

Phone: 405-947-3345

Enter a starting address:

Healthcare Info for Nancy Nagle MD

Additional Medical Specialties Include:
INTERNAL MEDICINE

Medical School: University Of Oklahoma College Of Medicine
Graduation Year: 1995
The Primary Medical Specialty for Nancy Nagle MD is listed as: Pulmonary Disease
Credentials: MD
Additional Credentials:
Approximate Years of Experience: 29
PAC (PECOS ID)#: 2567491418
NPI #: 1740245745
NPI Created On: 04/20/2006
NPI Last Updated Listed as: 10/15/2011
Primary Taxonomy Code: 207RP1001X
License Number:
19899
Listed Gender: Female

Insurance, Services, Charges

Forms of insurance accepted by include, but are not limited to:

Humana
Blue Cross Blue Shield
Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English.

Services and Procedures include:

Emergent insertion of breathing tube into windpipe cartilage using an endoscope
Measurement and graphic recording of total and timed exhaled air capacity
Measurement and graphic recording of the amount and speed of breathed air, before and following medication administration
Measurement and graphic recording of the amount and speed of breathed air, before and following medication administration
Determination of lung volumes using plethysmography
Determination of lung volumes using gas dilution or washout
Measurement of lung diffusing capacity
Measurement of lung diffusing capacity
New patient office or other outpatient visit, typically 45 minutes
New patient office or other outpatient visit, typically 60 minutes
Established patient office or other outpatient visit, typically 15 minutes
Established patient office or other outpatient, visit typically 25 minutes
Initial hospital inpatient care, typically 70 minutes per day
Subsequent hospital inpatient care, typically 25 minutes per day
Subsequent hospital inpatient care, typically 35 minutes per day
Hospital discharge day management, 30 minutes or less
Critical care delivery critically ill or injured patient, first 30-74 minutes

They took part in the Medicare Physician Quality Reporting System (PQRS).

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.

Payments Total: $13

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788627359

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Cardiovascular & Metabolism

Name of Drug #1: XARELTO

Open Associated Drug #1: 50458-580-30

Payments Total: $13

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788627361

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Cardiovascular & Metabolism

Name of Drug #1: XARELTO

Open Associated Drug #1: 50458-580-30

Payments Total: $18

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788627363

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Cardiovascular & Metabolism

Name of Drug #1: XARELTO

Open Associated Drug #1: 50458-580-30

Payments Total: $15

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 801744819

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: RESPIRATORY

Name of Drug #1: TRELEGY ELLIPTA

Open Associated Drug #1: 0173-0887-14

Payments Total: $20

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 801744869

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: RESPIRATORY

Name of Drug #1: ANORO ELLIPTA

Open Associated Drug #1: 0173-0869-06

Drug or Biological: Drug

Product Category #2: RESPIRATORY

Name Of Drug #2:: TRELEGY ELLIPTA

Associated Drug #2: 0173-0887-14

Payments Total: $16

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 802400301

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: RESPIRATORY

Name of Drug #1: TRELEGY ELLIPTA

Open Associated Drug #1: 0173-0887-14

Payments Total: $18

Number of Payments:: 1

Form of Payment: In-kind items and services

Ownership Interest: Yes

Third party is a Charity:: No

Record ID:: 835956167

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Immunology

Name of Drug #1: Xolair

Open Associated Drug #1: 50242-040-62

Drug or Biological: Biological

Product Category #2: Immunology

Name Of Drug #2:: Esbriet

Associated Drug #2: 50242-121-01

Payments Total: $19

Number of Payments:: 1

Form of Payment: In-kind items and services

Ownership Interest: Yes

Third party is a Charity:: No

Record ID:: 835956169

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Immunology

Name of Drug #1: Xolair

Open Associated Drug #1: 50242-040-62

Drug or Biological: Biological

Product Category #2: Immunology

Name Of Drug #2:: Esbriet

Associated Drug #2: 50242-121-01

Payments Total: $19

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 839125813

Being Disputed:: No

Product Related: No

Payments Total: $17

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 820104961

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: IMMUNOLOGY

Name of Drug #1: CUVITRU

Open Associated Drug #1: 0944-2850-01

Additional Office Locations

1. Integris Ambulatory Care Corporation
5501 N Portland
Oklahoma City, OK 73112
Select Specialty Hosp West
Group Members: 383

Phone: 405-947-3345

Enter a starting address:

2. Integris Ambulatory Care Corporation
3400 Nw Expressway
Oklahoma City, OK 73112
Suite 500
Group Members: 383

Phone: 405-947-3345

Enter a starting address:

Pulmonary Disease Professionals in Oklahoma City

1.
Stacey Foshee

3100 Sw 89th St
Oklahoma-city, OK

2.
Gregory Mckinnis MD

608 Nw 9th St
Oklahoma-city, OK

3.
Gregory Mckinnis MD

1000 N Lee Ave
Oklahoma-city, OK
Healthfirst Physicians Management Services, Inc.

4.
Gregory Mckinnis MD

3418 Nw 135th St
Oklahoma-city, OK
Nextgen Sleep Llc

5.
Kevin Oneal

5501 N Portland
Oklahoma-city, OK
Integris Ambulatory Care Corporation

6.
Kevin Oneal

3366 Nw Expressway
Oklahoma-city, OK
Integris Ambulatory Care Corporation

Providers in the same medical group

1.Jon Aagaard

2001 N Gary Ave
Wheaton Il 60187-3055
Family Practice

2.Matthew Aaker

8055 W Ave
Castle Hills Tx 78213-1842
Optometry

3.Justin Aaker

3613 Williams Dr
Georgetown Tx 78628-1373
Ophthalmology

4.Mohammad Aalai

7005 35th Ave
Jackson Heights Ny 11372-3970
Physical Medicine And Rehabilitation

5.Carol Aalbers Cp

4560 S Carson St
Carson City Nv 89701-6915
Clinical Psychologist

6.Hina Aamir

602 S Atwood Rd
Bel Air Md 21014-4323
Psychiatry